The firm will use the funds to develop a proof of concept and move its product through the FDA approval process.Read More
Tags :respira
The company is pursuing a prescription designation for its latest handheld smoking-cessation device.Read More
Respira Technologies is likely using a website to spread misinformation about nicotine vaping and EVALI.Read More
The technology represents the world’s first inhalable nicotine-replacement therapy, says manufacturer. Read More
Respira has appointed Brian W. Quigley, a 16 year veteran of Altria Group, as its Chief Operating Officer. Read More
Harm Reduction
News This Week
Next-Generation Products
Regulation
Respira to Submit Nebulizer For FDA Approval
The company says it aims to disrupt a $618 billion market dominated by decades-old gums and patches as well as electronic nicotine-delivery devices.Read More
